Evaluation and mechanism study of Pien Tze Huang against EV-A71 infection

Evaluation and mechanism study of Pien Tze Huang against EV-A71 infection

Hand, foot, and mouth disease (HFMD) caused by enterovirus A71 (EV-A71) infection, currently lacks specific preventive and therapeutic interventions. Here, we demonstrated that Pien Tze Huang (PZH) could dose-dependently inhibit EV-A71 replication at the cellular level, resulting in significant redu...

Full description

Bibliographic Details
Main Authors:	Huiqiang Wang, Fenbei Chen, Shicong Wang, Yuhuan Li, Ting Liu, Yinghong Li, Hongbin Deng, Jingwen Dong, Jing Pang, Danqing Song, Dousheng Zhang, Juan Yu, Yanxiang Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Pharmacology
Subjects:	enterovirus A71 Pien Tze Huang multicomponent drug host cytokine proteomics
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1251731/full

Similar Items

Therapeutic Potential of Pien-Tze-Huang: A Review on Its Chemical Composition, Pharmacology, and Clinical Application
by: Lili Huang, et al.
Published: (2019-09-01)

Pien Tze Huang alleviate the joint inflammation in collagen-induced arthritis mice
by: YongQi Deng, et al.
Published: (2020-03-01)

The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease
by: Baohuan Lian, et al.
Published: (2022-07-01)

Pien-tze-huang promotes wound healing in streptozotocin-induced diabetes models associated with improving oxidative stress via the Nrf2/ARE pathway
by: Ying Liu, et al.
Published: (2023-01-01)

Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
by: Xuemei Qiu, et al.
Published: (2018-10-01)

Traditional Chinese medicine Pien-Tze-Huang ameliorates LPS-induced sepsis through bile acid-mediated activation of TGR5-STAT3-A20 signalling
by: Bei Li, et al.
Published: (2024-04-01)

Case report: Treatment with Pien-Tze-Huang for prolonged positive SARS-CoV-2 test results in COVID-19 patients: A report of five cases
by: Yujiao Zheng, et al.
Published: (2022-08-01)

Integrating RNA-sequencing and network analysis to explore the mechanism of topical Pien Tze Huang treatment on diabetic wounds
by: Guang-Zhao Cao, et al.
Published: (2024-01-01)

Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis
by: Xiangying Yan, et al.
Published: (2023-06-01)

Pien-Tze-Huang alleviates CCl4-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway
by: Yuqin Zhang, et al.
Published: (2022-09-01)

From non-targeted to targeted GC–MS metabolomics strategy for identification of TCM preparations containing natural and artificial musk
by: Meng Ding, et al.
Published: (2022-04-01)

First isolation of enterovirus 71 (EV-71) from Northern Brazil
by: Lamarão Leticia Martins, et al.
Published: (2003-01-01)

Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy
by: Huiqiang Wang, et al.
Published: (2019-08-01)

Yakammaoto inhibits enterovirus 71 infection by reducing viral attachment, internalization, replication, and translation
by: Chia-Feng Yeh, et al.
Published: (2015-06-01)

Pien Tze Huang regulates phosphorylation of metabolic enzymes in mice of hepatocellular carcinoma
by: Jinxia Lin, et al.
Published: (2023-02-01)

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy
by: Pei Liu, et al.
Published: (2021-04-01)

Discovery of Gramine Derivatives That Inhibit the Early Stage of EV71 Replication in Vitro
by: Yanhong Wei, et al.
Published: (2014-06-01)

Otto Piene, Bronze and Gold III, 1959
by: Michael Brötje
Published: (2010-06-01)

Effects and mechanism of Aβ1−42 on EV-A71 replication
by: Ming Zhong, et al.
Published: (2022-09-01)

Preparation and identification of the epitope peptide polyclonal antisera against capsid proteins of EV71
by: LI Chen, ZHANG Ting, WANG Zhi-rong, XU Xue-mei
Published: (2022-11-01)

Muscle Tissue Damage and Recovery After EV71 Infection Correspond to Dynamic Macrophage Phenotypes
by: Mei-Yi Lu, et al.
Published: (2021-07-01)

A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge
by: Yu-Li Lin, et al.
Published: (2023-12-01)

Tribbles pseudokinase 3 promotes enterovirus A71 infection via dual mechanisms
by: Huiqiang Wang, et al.
Published: (2024-12-01)

Epidemiology of Enterovirus 71 Infections in Taiwan
by: Min-Yuan Chia, et al.
Published: (2014-08-01)

Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
by: Salima Lalani, et al.
Published: (2021-08-01)

Enterovirus A71 Meningoencephalitis Outbreak, Rostov-on-Don, Russia, 2013
by: Ludmila V. Akhmadishina, et al.
Published: (2015-08-01)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Salima S. Lalani, et al.
Published: (2020-03-01)

Reverse Genetic Approaches for the Generation of Full Length and Subgenomic Replicon of EV71 Virus
by: Hang Yang, et al.
Published: (2021-05-01)

Suppression of interleukin-6 increases enterovirus A71 lethality in mice
by: Li-Chiu Wang, et al.
Published: (2017-12-01)

Enterovirus A71 Infection, Thailand, 2017
by: Jiratchaya Puenpa, et al.
Published: (2018-07-01)

Antivirals and vaccines for Enterovirus A71
by: Jing-Yi Lin, et al.
Published: (2019-09-01)

Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke
by: Kwong Wing, et al.
Published: (2010-10-01)

Valine/isoleucine variants drive selective pressure in the VP1 sequence of EV-A71 enteroviruses
by: Nghia Ngu Duy, et al.
Published: (2017-05-01)

EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors
by: Kanghong Hu, et al.
Published: (2023-03-01)

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo
by: Peijun Ren, et al.
Published: (2014-01-01)

Monoclonal antibody against EV71 3Dpol inhibits the polymerase activity of RdRp and virus replication
by: Yaoming Li, et al.
Published: (2019-01-01)

The neuropathological mechanism of EV-A71 infection attributes to inflammatory pryoptosis and viral replication via activating the hsa_circ_0045431/ hsa_miR_584/NLRP3 regulatory axis
by: Yajie Hu, et al.
Published: (2023-10-01)

Advances in anti-EV-A71 drug development research
by: Shuqi Wang, et al.
Published: (2024-02-01)

Anti-Enterovirus 71 Agents of Natural Products
by: Liyan Wang, et al.
Published: (2015-09-01)

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
by: Qunying Mao, et al.
Published: (2016-01-01)